Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Son, Cheol Hun ^d   Keum, Jin Hee ^a   Yang, Kwangmo ^d   Nam, Jiho ^c   Kim, Mi Ju ^a,b   Kim, Sun Hee ^a,b   Kang, Chi Dug ^a   Oh, Sae Ock ^a,b   Kim, Chi Dae ^a,b   Park, You Soo ^d   Bae, Jaeho ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Pusan National University Yangsan Hospital   (South Korea)

^d Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

HDAC inhibitors; Ionizing radiation; NKG2D ligands; Radioresistance

Indexed keywords

CARCINOMA, NON-SMALL-CELL LUNG; CELLS, CULTURED; COMBINED MODALITY THERAPY; CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LUNG NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RADIATION TOLERANCE; RADIATION, IONIZING; UP-REGULATION;

EID: 84893693195     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-49     Document Type: Article

References (33)

1. Schmitt C, Ghazi B, Bensussan A. NK cells and surveillance in humans. Reprod Biomed Online 2008, 16:192-201. 10.1016/S1472-6483(10)60574-3, 18284872.
2. Lanier LL. NK cell recognition. Annu Rev Immunol 2005, 23:225-274. 10.1146/annurev.immunol.23.021704.115526, 15771571.
3. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729. 10.1126/science.285.5428.727, 10426993.
4. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010, 235:267-285. 2885032, 20536569.
5. Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol 2007, 178:961-969.
6. Vales-Gomez M, Chisholm SE, Cassady-Cain RL, Roda-Navarro P, Reyburn HT. Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res 2008, 68:1546-1554. 10.1158/0008-5472.CAN-07-2973, 18316620.
7. Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT. Proteasome regulation of ULBP1 transcription. J Immunol 2009, 182:6600-6609. 10.4049/jimmunol.0801214, 2748925, 19414815.
8. Kim JY, Son YO, Park SW, Bae JH, Chung JS, Kim HH, Chung BS, Kim SH, Kang CD. Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med 2006, 38:474-484. 10.1038/emm.2006.56, 17079863.
9. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190. 10.1038/nature03884, 1352168, 15995699.
10. Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM. Modulation of radiation response by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys 2005, 62:223-229. 10.1016/j.ijrobp.2004.12.088, 15850925.
11. Yu J, Mi J, Wang Y, Wang A, Tian X. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela. Eur J Gynaecol Oncol 2012, 33:285-290.
12. Shoji M, Ninomiya I, Makino I, Kinoshita J, Nakamura K, Oyama K, Nakagawara H, Fujita H, Tajima H, Takamura H, et al. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma. Int J Oncol 2012, 40:2140-2146.
13. Banuelos CA, Banath JP, MacPhail SH, Zhao J, Reitsema T, Olive PL. Radiosensitization by the histone deacetylase inhibitor PCI-24781. Clin Cancer Res 2007, 13:6816-6826. 10.1158/1078-0432.CCR-07-1126, 18006784.
14. Skov S, Pedersen MT, Andresen L, Straten PT, Woetmann A, Odum N. Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res 2005, 65:11136-11145. 10.1158/0008-5472.CAN-05-0599, 16322264.
15. Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, et al. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 2005, 65:6321-6329. 10.1158/0008-5472.CAN-04-4252, 16024634.
16. Park SW, Bae JH, Kim SD, Son YO, Kim JY, Park HJ, Lee CH, Park DY, Lee MK, Chung BS, et al. Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR. Cancer Invest 2007, 25:299-307. 10.1080/07357900701208824, 17661204.
17. Bae JH, Kim JY, Kim MJ, Chang SH, Park YS, Son CH, Park SJ, Chung JS, Lee EY, Kim SH, et al. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J Immunother 2010, 33:391-401. 10.1097/CJI.0b013e3181d32f22, 20386467.
18. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-1059. 10.1038/nm1622, 17704786.
19. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007, 7:329-339. 10.1038/nri2073, 17438573.
20. Eagle RA, Jafferji I, Barrow AD. Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells. Curr Immunol Rev 2009, 5:22-34. 10.2174/157339509787314369, 2713595, 19626129.
21. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001, 2:255-260. 10.1038/85321, 11224526.
22. Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 291:L222-L231. 10.1152/ajplung.00327.2005, 16473864.
23. Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV, Bates SE. P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Br J Cancer 2000, 83:817-825. 10.1054/bjoc.2000.1327, 2363539, 10952788.
24. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005, 102:16090-16095. 10.1073/pnas.0505585102, 1276064, 16243973.
25. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001, 10:687-692. 10.1093/hmg/10.7.687, 11257100.
26. Lopez-Soto A, Folgueras AR, Seto E, Gonzalez S. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene 2009, 28:2370-2382. 10.1038/onc.2009.117, 19430493.
27. Kim W, Youn H, Seong KM, Yang HJ, Yun YJ, Kwon T, Kim YH, Lee JY, Jin YW, Youn B. PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases. Radiat Res 2011, 176:539-552. 10.1667/RR2609.1, 21910584.
28. Kim H, Kim SH, Kim MJ, Kim SJ, Park SJ, Chung JS, Bae JH, Kang CD. EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells. J Immunother 2011, 34:372-381. 10.1097/CJI.0b013e31821b724a, 21499124.
29. Tetsuo M, Tomoko O, Shigeo S, Mikiko M, Yoshikazu S, Kanami Y, Jun-ichi H, Mitsuhiro T, Tetsuya M, Yuichi I, Yo K, Hiroshi T, Takao Y, Takashi T. p53-Defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J Natl Cancer Inst 2005, 97:765-777. 10.1093/jnci/dji133, 15900046.
30. Bae JH, Kim SJ, Kim MJ, Oh SO, Chung JS, Kim SH, Kang CD. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction. Cancer Sci 2012, 103:7-16. 10.1111/j.1349-7006.2011.02109.x, 21951556.
31. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996, 93:12445-12450. 10.1073/pnas.93.22.12445, 38011, 8901601.
32. Molinero LL, Domaica CI, Fuertes MB, Girart MV, Rossi LE, Zwirner NW. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity. Hum Immunol 2006, 67:170-182. 10.1016/j.humimm.2006.02.010, 16698439.
33. Fuertes MB, Girart MV, Molinero LL, Domaica CI, Rossi LE, Barrio MM, Mordoh J, Rabinovich GA, Zwirner NW. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol 2008, 180:4606-4614.